NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
February 6, 2026 — LIXTE Biotechnology's LB-100 compound enhances cancer immunotherapy & chemotherapy effectiveness by targeting PP2A enzyme. Clinical trials show promise for ovarian & colon cancers.
February 6, 2026 — LIXTE Biotechnology advances cancer treatment with LB-100, a PP2A inhibitor designed to enhance existing immunotherapy and chemotherapy, targeting resistance in clinical trials for ovarian and colon cancers.
February 6, 2026 — Soligenix announces positive Phase 2 results for SGX945 in Behçet's disease, a rare inflammatory condition. The novel therapy shows promise as a safe, immune-modulating treatment for underserved patients.
February 6, 2026 — Phase III trial shows loberamisal, a novel neuroprotective drug, improves stroke recovery with 69% excellent outcomes. Presented at American Stroke Association conference.
February 6, 2026 — New I-ACQUIRE therapy improves arm function in toddlers after stroke. High-dose, home-based treatment shows lasting benefits vs. usual care in a major clinical trial.
February 6, 2026 — Lionheart Health partners with Rejuvant in XPRIZE Healthspan Semi-Finals, integrating CaAKG supplements with multi-modal healthspan optimization including personalized nutrition and bioelectric exercise.
February 6, 2026 — New light-activated therapy targets microscopic brain cancer cells after surgery. Preclinical study shows promise for eliminating residual cancer tissue that surgeons cannot see during tumor removal.
February 6, 2026 — Albrechtsen & Fanelli Orthodontics now offers MARPE treatment in Utah, a non-surgical solution for narrow palates in teens and adults. Learn about this advanced orthodontic care.
February 6, 2026 — Healthcare pros endorse Deeply Unimportant podcast for sleep aid, using cognitive shuffling to calm racing thoughts in ADHD/OCD. Hosted by ex-newscaster Dallas Kachan.
February 5, 2026 — LIXTE Biotechnology enhances cancer therapies by targeting treatment resistance with LB-100 compound. Clinical trials show promise for ovarian, colon & sarcoma cancers. Learn about this innovative approach to improving existing treatments.
February 5, 2026 — New anti-clotting drug asundexian reduces second stroke risk by 26% without increasing bleeding, per American Stroke Association trial. Could transform stroke prevention.
February 5, 2026 — MedCognetics receives FDA 510(k) clearance for CogNet AI-MT+, an AI tool for breast imaging triage. Enhances early cancer detection with unbiased algorithms trained on diverse global data.
February 5, 2026 — TransCode Therapeutics submits IND amendment for Phase 2a trial of TTX-MC138 targeting metastatic colorectal cancer. Trial to enroll ctDNA-positive patients in PRE-I-SPY program starting 2026.
February 5, 2026 — Telomir Pharmaceuticals reveals Telomir-1 cellular study showing novel intracellular metal modulation, increasing zinc while reducing iron to address aging and cancer mechanisms. Preclinical data published via BioMedWire.
February 5, 2026 — Researchers develop yeast cell platform to accelerate cancer immunotherapy development, reducing costs and time in drug testing. Calidi Biotherapeutics explores cutting-edge approaches.
February 5, 2026 — Join the American Heart Association's Go Red for Women movement on National Wear Red Day, Feb 6, 2026. Learn 4 ways to support women's heart health, wear red, and help fight cardiovascular disease.
February 5, 2026 — Hodo tofu helps you eat healthier with affordable, protein-packed plant-based meals. Aligns with new Dietary Guidelines, addresses grocery cost concerns, and offers convenient recipes from experts.
February 5, 2026 — Surgeon Dr. Sharona Ross transforms near-fatal accident into advocacy for women's self-care in high-pressure professions. Shares recovery journey at Women in Surgery Symposium.
February 5, 2026 — Scottsdale Detox launches a new comprehensive detox service for drug and alcohol addiction, offering personalized care and holistic recovery in Arizona. Learn more.
February 4, 2026 — American Heart Association & NFL award grants to 136 schools to boost student physical activity through NFL PLAY 60 and Kids Heart Challenge programs, addressing youth fitness crisis.